MedPath

Personal Therapy Comfort Settings Pilot Clinical Study

Not Applicable
Completed
Conditions
Obstructive Sleep Apnea
Interventions
Device: continuous positive airway pressure (CPAP)
Registration Number
NCT05376137
Lead Sponsor
ResMed
Brief Summary

350 participants will be enrolled in this study. The target population are patients newly diagnosed with OSA and starting CPAP treatment.

User accessible customizable comfort settings (Response setting, expiratory pressure relief (EPR) on/off and EPR level, and Ramp) will be set to either default (control group), or personalized for that participant (active treatment group).

Usage will be recorded for the first 1 month of CPAP treatment, to determine if customizing comfort settings can improve CPAP compliance

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
66
Inclusion Criteria
  • Patients willing to give written informed consent
  • Patients who can read and comprehend English
  • Patients who are ≥ 18 years of age
  • Patients newly diagnosed with OSA and indicated for CPAP therapy.
Exclusion Criteria
  • Patients who have previously used PAP therapy

  • Patients who require a bilevel device

  • Patients who are or may be pregnant

    * Patients who are unable to attend follow up appointments

  • Patients with a preexisting lung disease/ condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (< 2years) case of pneumonia or lung infection; lung injury

  • Patients believed to be unsuitable for inclusion by the researcher

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Default comfort settingscontinuous positive airway pressure (CPAP)Comfort settings will be set to default (out of the box setttings)
Personalized Therapy Comfort Settingscontinuous positive airway pressure (CPAP)Comfort settings will be personalized to each user
Primary Outcome Measures
NameTimeMethod
Comparison of treatment continuance between the control group and active treatment group.4 weeks after commencement of CPAP

Patients who drop off treatment (stop using CPAP treatment) in each group will be compared after 1.5 months of CPAP treatment.

Secondary Outcome Measures
NameTimeMethod
Mask leak4 weeks after commencement of CPAP

Mask leak will be compared between the two groups

comparison of compliance between the control group and active treatment group4 weeks after commencement of CPAP

Usage will be compared between the two groups

Treatment efficacy4 weeks after commencement of CPAP

Residual Apnea-hypopnea index will be compared between the two groups

Settings changes4 weeks after commencement of CPAP

Number of comfort settings changes will be compared between the two groups

Ad hoc contacts4 weeks after commencement of CPAP

Number of ad hoc contacts between participants and clinicians will be compared between the two groups

Trial Locations

Locations (1)

ResMed Centre for Healthy Sleep

🇦🇺

Bella Vista, New South Wales, Australia

© Copyright 2025. All Rights Reserved by MedPath